WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 11'1101 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 14'7571 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 21  21  21  21  20  19  15  12 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported case

(Click for retrospective incidence data for Palau)
Diphtheria
Japanese encephalitis
Measles
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Palau)
Vaccine year result method % card seen                                                
BCG         
DTP1          99*  99*  99*  99*  99  95 
DTP3          95  99  89  84  69  96 
DTP4          93 
IPV1          99* 
HepB_BD          99*  99*  99*  99*  99*  99* 
HepB3          99*  99  89  91  80  96 
Hib3          99*  99  89  85  66  96 
JapEnc         
MCV1          83  99  91  85  39  83 
MCV2          81  98  86  83  75 
PCV1          99*  99*  86  95  87 
PCV3          93  93  82  61  45 
Pol3          95  99  89  98  68  96 
Rota1          99*  99*  99*  98  89 
Rota_last          99*  99  89  89  76 
Rubella1          83  99  91  85 
TT2plus          26 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Palau)
DTP1 99  99  99  99  99  98  99 
DTP3 95  99  89  84  69  96  99 
HepB3 99  99  89  91  80  96 
HepB_BD 99  99  99  99  99  99 
Hib3 99  99  89  85  66  96 
MCV1 83  99  91  85  39  83  98 
MCV2 81  98  86  83  39  75 
PCV3 93  93  82  61  45 
Pol3 95  99  89  98  68  96  99 
Rota_last 99  99  89  89  76 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaP 14 months; 4-5 years; Yes
DTaPHepIPV 6 week; 4, 6 months; Yes
HPV 9-26 years; +2, +6 months; Yes
HepB_Adult 1st contact; +1, +6 months;
HepB_Pediatric birth; 6 weeks; 6 months;
Hib 6 weeks; 4, 6, 12 months; Yes
IPV 4-5 years; Yes
Influenza_Adult >= 55 years; Yes and adults with chronic diseases, pregnant women, health care workers, and other risk groups
Influenza_Pediatric Yes children with chronic diseases
MMR 12, 15 months; Yes
MenC_conj 11-13 years; Yes
Pneumo_conj 3, 5, 7, 15 months; Yes
Rotavirus 6 week; 4, 6 months; Yes
Td 5-10 years; Yes
Tdap 7-49 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  Yes  Yes  No  Yes 
What years does the MYP cover? number       2'012  2010-2011    2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number      

System performance

Total Nº districts in country number          
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100%           100 
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%             100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%  

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No       

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.